StockData

Yubo International Biotech Ltd (YBGJ) stock

YBGJOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$0.01+0.00 (0.00%)

Close on Oct 16, 2026Market cap $886.19KP/E –Yield –

Yubo International Biotech operating margin

Operating margin is operating income as a percentage of revenue.

Yubo International Biotech's operating margin for the twelve months ending Jun 30, 2026 was -9096.9%. For fiscal 2026 it was -9614.6%, against -51006.3% the year before. The highest annual figure on record is -124.0% in fiscal 2022.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2026Dec 31, 2025-9614.6%+41391.7
FY2025Dec 31, 2024-51006.3%−50808.7
FY2024Dec 31, 2023-197.6%+958.1
FY2023Dec 31, 2022-1155.7%−1031.7
FY2022Dec 31, 2021-124.0%–

Quarterly operating margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q4 FY2026CQ4 2025Dec 31, 2025-2310.9%+23372.7
Q1 FY2025CQ1 2024Mar 31, 2024-11738.0%−11535.9
Q4 FY2024CQ4 2023Dec 31, 2023-2321.3%−2476.8
Q3 FY2024CQ3 2023Sep 30, 20231.5%+1635.7
Q2 FY2024CQ2 2023Jun 30, 2023-25683.6%−19516.8
Q1 FY2024CQ1 2023Mar 31, 2023-202.1%+3603.4
Q4 FY2023CQ4 2022Dec 31, 2022155.6%+272.4
Q3 FY2023CQ3 2022Sep 30, 2022-1634.2%−1282.2
Q2 FY2023CQ2 2022Jun 30, 2022-6166.9%–
Q1 FY2023CQ1 2022Mar 31, 2022-3805.5%–
Q4 FY2022CQ4 2021Dec 31, 2021-116.8%–
Q3 FY2022CQ3 2021Sep 30, 2021-352.0%–

More Yubo International Biotech figures

See a number that looks wrong?